|
Diabetes, Vol 48, Issue 5 1054-1060, Copyright © 1999 by American Diabetes Association
Endogenous glucose production and glucose effectiveness in type 2 diabetic subjects derived from stable-labeled minimal model approach
S Nagasaka, K Tokuyama, I Kusaka, H Hayashi, K Rokkaku, T Nakamura, A Kawakami, M Higashiyama, S Ishikawa and T Saito
Department of Medicine, Jichi Medical School, Tochigi, Japan. sngsk@jichi.ac.jp
Insulin sensitivity, glucose effectiveness, and endogenous glucose
production (EGP) during stable-labeled, frequently sampled insulin-modified
intravenous glucose tolerance test (FSIGT) were evaluated by a single-and
two-compartment minimal model combined with nonparametric deconvolution in
eleven nonobese Japanese type 2 diabetic patients. Four patients were
treated with sulfonylureas, and the remaining seven with diet therapy
alone. None had diabetic retinopathy and microalbuminuria. Their fasting
glucose level was 117+/-7 mg/dl (mean +/- SE), and HbA1c was 6.6+/-0.3%.
Age-, sex-, and BMI-matched subjects with normal glucose tolerance served
as control subjects. Plasma insulin response to the stimuli and insulin
sensitivity indexes (S(I), S(I)*, and S(I)2* were derived from a minimal
model and single- and two-compartment-labeled minimal models) were impaired
in the type 2 diabetic patients. The combined ability of glucose, per se,
to increase its own uptake and suppress EGP (glucose effectiveness [SG]),
which was derived from kinetic analysis of plasma glucose by a minimal
model, was significantly lower in the type 2 diabetic patients
(0.0132+/-0.0015 vs. 0.0203+/-0.0022; P<0.05). However, the ability of
glucose, per se, to stimulate glucose uptake, assessed as S(G)* and S(G)2*
from the kinetic analysis of labeled glucose by single- and two-compartment
minimal model, was not impaired in those patients. EGP of the type 2
diabetic patients as a whole was suppressed to the level similar to that of
the control subjects despite a higher plasma glucose level throughout
FSIGT. When EGP in the diabetic subjects was analyzed, considering their
recent glycemic control, the initial suppression was blunted in the
patients with higher HbA1c levels. In conclusion, glucose mass action to
stimulate glucose uptake remains near-normal in the lean Japanese type 2
diabetic patients of this study, whereas ability of glucose to suppress EGP
is impaired in the patients with recent hyperglycemia. This blunted
suppression of EGP might be one of the conspirators for decreased S(G) in
subjects with type 2 diabetes.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Hayashi, S. Nagasaka, N. Takahashi, I. Kusaka, S. Ishibashi, S. Numao, D. J. Lee, Y. Taki, H. Ogata, K. Tokuyama, et al.
A Single Bout of Exercise at Higher Intensity Enhances Glucose Effectiveness in Sedentary Men
J. Clin. Endocrinol. Metab.,
July 1, 2005;
90(7):
4035 - 4040.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. S. Meneilly and D. Elahi
Metabolic Alterations in Middle-Aged and Elderly Lean Patients With Type 2 Diabetes
Diabetes Care,
June 1, 2005;
28(6):
1498 - 1499.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Krudys, M. G. Dodds, S. M. Nissen, and P. Vicini
Integrated model of hepatic and peripheral glucose regulation for estimation of endogenous glucose production during the hot IVGTT
Am J Physiol Endocrinol Metab,
May 1, 2005;
288(5):
E1038 - E1046.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Suzuki, K. Tobe, M. Aoyama, A. Inoue, K. Sakamoto, T. Yamauchi, J. Kamon, N. Kubota, Y. Terauchi, H. Yoshimatsu, et al.
Both Insulin Signaling Defects in the Liver and Obesity Contribute to Insulin Resistance and Cause Diabetes in Irs2-/- Mice
J. Biol. Chem.,
June 11, 2004;
279(24):
25039 - 25049.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Oberkofler, V. Linnemayr, R. Weitgasser, K. Klein, M. Xie, B. Iglseder, F. Krempler, B. Paulweber, and W. Patsch
Complex Haplotypes of the PGC-1{alpha} Gene Are Associated With Carbohydrate Metabolism and Type 2 Diabetes
Diabetes,
May 1, 2004;
53(5):
1385 - 1393.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Nishida, K. Tokuyama, S. Nagasaka, Y. Higaki, Y. Shirai, A. Kiyonaga, M. Shindo, I. Kusaka, T. Nakamura, S. Ishibashi, et al.
Effect of Moderate Exercise Training on Peripheral Glucose Effectiveness, Insulin Sensitivity, and Endogenous Glucose Production in Healthy Humans Estimated by a Two-Compartment-Labeled Minimal Model
Diabetes,
February 1, 2004;
53(2):
315 - 320.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. Toffolo and C. Cobelli
The hot IVGTT two-compartment minimal model: an improved version
Am J Physiol Endocrinol Metab,
February 1, 2003;
284(2):
E317 - E321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Nishida, K. Tokuyama, S. Nagasaka, Y. Higaki, K. Fujimi, A. Kiyonaga, M. Shindo, I. Kusaka, T. Nakamura, S.-E Ishikawa, et al.
SG, SI, and EGP of exercise-trained middle-aged men estimated by a two-compartment labeled minimal model
Am J Physiol Endocrinol Metab,
October 1, 2002;
283(4):
E809 - E816.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Vicini, A. Avogaro, M. E. Spilker, A. Gallo, and C. Cobelli
Epinephrine effects on insulin-glucose dynamics: the labeled IVGTT two-compartment minimal model approach
Am J Physiol Endocrinol Metab,
July 1, 2002;
283(1):
E78 - E84.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hawkins, I. Gabriely, R. Wozniak, K. Reddy, L. Rossetti, and H. Shamoon
Glycemic Control Determines Hepatic and Peripheral Glucose Effectiveness in Type 2 Diabetic Subjects
Diabetes,
July 1, 2002;
51(7):
2179 - 2189.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Diabetes Association.
|
|
| |
|